Skip to main content

Hyperion Defi, Inc.

HYPD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001682639

No open-market purchases or sales by Hyperion Defi, Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $7.92M in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding Hyperion Defi, Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of HYPD: Q3 2022 compared with Q4 2022
MeasureQ3 2022Of which not filed for Q4 2022Q4 2022Change
Holders30127−2
Shares2.17M2.00K2.97M+798.6K (+36.9%)
Value$4.25M$3.91K$4.83M+$588.3K (+13.9%)

1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (4)

Institutions that held Hyperion Defi, Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to HYPD in Q4 2022
InstitutionSharesValue% of portfolio
Lasry Marc547,807$892.9K1.39%
Ameriprise Financial Inc336,432$548.0K0.00%
Virtu Financial LLC16,230$26.0K0.00%
Advisor Group Holdings, Inc.2,000$3.26K0.00%

Sold out (6)

Institutions that held Hyperion Defi, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of HYPD in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Financial Management Network Inc55,000$118.0K
Prudential Financial Inc17,000$33.0K
Citadel Advisors LLC12,373$24.0K
Hexagon Capital Partners LLC10,000$20.0K
Group One Trading, L.P.6,984$14.0K
Simplex Trading, LLC3,394$6.00K

Not filed for Q4 2022 yet (1)

Institutions that held Hyperion Defi, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding HYPD in Q3 2022 that haven't filed for Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
American Portfolios Advisors2,000$3.91K